Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 119Terminated 35Recruiting 21Unknown 16Withdrawn 11Active not recruiting 8Not yet recruiting 3No longer available 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 141Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Leukemia 36Leukemia, Lymphocytic, Chronic, B-Cell 34Myelodysplastic Syndromes 24Recurrence 23Lymphoma 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Neoplasms 14Multiple Myeloma 9Motor Activity 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasm, Residual 8Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 8Lymphoma, B-Cell 8Leukemia, B-Cell 8Lymphoma, Mantle-Cell 6Burkitt Lymphoma 6Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Plasma Cell 5Leukemia, Myeloid, Chronic-Phase 5Febrile Neutropenia 5Waldenstrom Macroglobulinemia 4Pain 4Neoplasm Metastasis 4Leukemia, Myelomonocytic, Chronic 4

Interventions

Cyclophosphamide 2ruxolitinib 1fludarabine 1blinatumomab 1Thiotepa 1Busulfan 1Antilymphocyte Serum 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Graft vs Host Disease × Other hematologic neoplasm × Clear all
NCT07565220 2026-05-04

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

University of Pittsburgh

Phase 1 Not yet recruiting
48 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07297914 2025-12-22

FORUM2

Bambino Gesù Hospital and Research Institute

Phase 2/3 Not yet recruiting
1,000 enrolled
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06238245 2024-02-20

Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Beijing 302 Hospital

Phase 2 Not yet recruiting
22 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡